PUBLICATIONS

2026

Targeting chordoma via an isocitrate dehydrogenase-1-dependent susceptibility to redox metabolism

Pun M, Deogharkar A, Natarajan SK, Nuechterlein N, Tian W, Ji S, Young E, Yang F, Hawes D, Andren AC, Owen JH, Rau S, Su F, Cao X, Parolia A, Prince M, Fry J, Gardner PA, Yang R, Judkins AR, Koschmann CJ, Venteicher AS, Lyssiotis CA, Chinnaiyan AM, Venneti S.

Acta Neuropathol. 2026 Jul 23;152(1):10. doi: 10.1007/s00401-026-03048-9.

ZFTA-RELA ependymomas make itaconate to epigenetically drive fusion expression

Natarajan SK, Lum J, Skeans JH, Nenwani M, Eyunni S, Mota M, Bayliss J, Deogharkar A, Hamanishi ET, Pun M, Sweha SR, Hoffman S, Young E, Zhang Q, Mehta R, Animasahun O, Narayanan P, Sunil S, Parolia A, Sajjakulnukit P, Panwalkar P, Doherty R, Clausen M, Dang D, Hawes D, Yang F, Santi M, Judkins AR, Wilson Y, Vigil T, Franson A, Mortensen RM, Ozawa T, Griesinger A, Holland EC, Foreman NK, Michealraj KA, Agnihotri S, Taylor M, Gilbertson RJ, Koschmann C, Chinnaiyan AM, Lyssiotis CA, Nagrath D, Venneti S.

Nature. 2026 Apr;652(8111):1004-1015. doi: 10.1038/s41586-025-10005-1. Epub 2026 Feb 4

Integration and Intersection of Cancer Metabolism with Epigenetic Pathways in Gliomas

Natarajan SK, Pun M, Haggerty-Skeans J, Venneti S.

Annu Rev Pathol. 2026 Jan;21(1):447-477. doi: 10.1146/annurev-pathmechdis-111523-023424. Epub 2025

2025

Aberrant histone modifications in pediatric brain tumors.

Hamanishi ET, Dang D, Venneti S.

Front Oncol. 2025 Jun 10;15:1587157. doi: 10.3389/fonc.2025.1587157. eCollection 2025.

Isocitrate dehydrogenase 1 primes group-3 medulloblastomas for cuproptosis

Dang D, Deogharkar A, McKolay J, Smith KS, Panwalkar P, Hoffman S, Tian W, Ji S, Azambuja AP, Natarajan SK, Lum J, Bayliss J, Manzeck K, Sweha SR, Hamanishi E, Pun M, Patel D, Rau S, Animasahun O, Achreja A, Ogrodzinski MP, Diessl J, Cotter J, Hawes D, Yang F, Doherty R, Franson AT, Hanaford AR, Eberhart CG, Raabe EH, Orr BA, Wechsler-Reya RJ, Chen B, Lyssiotis CA, Shah YM, Lunt SY, Banerjee R, Judkins AR, Prensner JR, Koschmann C, Waszak SM, Nagrath D, Simoes-Costa M, Northcott PA, Venneti S.

Cancer Cell. 2025 Jun 9;43(6):1159-1174.e8. doi: 10.1016/j.ccell.2025.04.013. Epub 2025 May 15

2024

A road map for the treatment of pediatric diffuse midline glioma.

Koschmann C, Al-Holou WN, Alonso MM, Anastas J, Bandopadhayay P, Barron T, Becher O, Cartaxo R, Castro MG, Chung C, Clausen M, Dang D, Doherty R, Duchatel R, Dun M, Filbin M, Franson A, Galban S, Garcia Moure M, Garton H, Gowda P, Marques JG, Hawkins C, Heath A, Hulleman E, Ji S, Jones C, Kilburn L, Kline C, Koldobskiy MA, Lim D, Lowenstein PR, Lu QR, Lum J, Mack S, Magge S, Marini B, Martin D, Marupudi N, Messinger D, Mody R, Morgan M, Mota M, Muraszko K, Mueller S, Natarajan SK, Nazarian J, Niculcea M, Nuechterlein N, Okada H, Opipari V, Pai MP, Pal S, Peterson E, Phoenix T, Prensner JR, Pun M, Raju GP, Reitman ZJ, Resnick A, Rogawski D, Saratsis A, Sbergio SG, Souweidane M, Stafford JM, Tzaridis T, Venkataraman S, Vittorio O, Wadden J, Wahl D, Wechsler-Reya RJ, Yadav VN, Zhang X, Zhang Q, Venneti S.

Cancer Cell. 2024 Jan 8;42(1):1-5. doi: 10.1016/j.ccell.2023.11.002. Epub 2023 Nov 30.

2023

Targeting SWI/SNF ATPases in H3.3K27M diffuse intrinsic pontine gliomas.

Mota M, Sweha SR, Pun M, Natarajan SK, Ding Y, Chung C, Hawes D, Yang F, Judkins AR, Samajdar S, Cao X, Xiao L, Parolia A, Chinnaiyan AM, Venneti S.

Proc Natl Acad Sci U S A. 2023 May 2;120(18):e2221175120. doi: 10.1073/pnas.2221175120. Epub 2023 Apr 24.

Common molecular features of H3K27M DMGs and PFA ependymomas map to hindbrain developmental pathways.

Pun M, Pratt D, Nano PR, Joshi PK, Jiang L, Englinger B, Rao A, Cieslik M, Chinnaiyan AM, Aldape K, Pfister S, Filbin MG, Bhaduri A, Venneti S.

Acta Neuropathol Commun. 2023 Feb 9;11(1):25. doi: 10.1186/s40478-023-01514-z.

2022

Glioblastoma stem cell HISTArionics.

Natarajan SK, Venneti S.

Cell Stem Cell. 2022 Nov 3;29(11):1509-1510. doi: 10.1016/j.stem.2022.10.004.

2021

Epigenetically defined therapeutic targeting in H3.3G34R/V high-grade gliomas.

Sweha SR, Chung C, Natarajan SK, Panwalkar P, Pun M, Ghali A, Bayliss J, Pratt D, Shankar A, Ravikumar V, Rao A, Cieslik M, Wilder-Romans K, Scott AJ, Wahl DR, Jessa S, Kleinman CL, Jabado N, Mackay A, Jones C, Martinez D, Santi M, Judkins AR, Yadav VN, Qin T, Phoenix TN, Koschmann CJ, Baker SJ, Chinnaiyan AM, Venneti S.

Sci Transl Med. 2021 Oct 13;13(615):eabf7860. doi: 10.1126/scitranslmed.abf7860. Epub 2021 Oct 13.

Targeting integrated epigenetic and metabolic pathways in lethal childhood PFA ependymomas.

Panwalkar P, Tamrazi B, Dang D, Chung C, Sweha S, Natarajan SK, Pun M, Bayliss J, Ogrodzinski MP, Pratt D, Mullan B, Hawes D, Yang F, Lu C, Sabari BR, Achreja A, Heon J, Animasahun O, Cieslik M, Dunham C, Yip S, Hukin J, Phillips JJ, Bornhorst M, Griesinger AM, Donson AM, Foreman NK, Garton HJL, Heth J, Muraszko K, Nazarian J, Koschmann C, Jiang L, Filbin MG, Nagrath D, Kool M, Korshunov A, Pfister SM, Gilbertson RJ, Allis CD, Chinnaiyan AM, Lunt SY, Blüml S, Judkins AR, Venneti S.

Sci Transl Med. 2021 Oct 6;13(614):eabc0497. doi: 10.1126/scitranslmed.abc0497. Epub 2021 Oct 6.

2020

Integrated Metabolic and Epigenomic Reprograming by H3K27M Mutations in Diffuse Intrinsic Pontine Gliomas.

Chung C, Sweha SR, Pratt D, Tamrazi B, Panwalkar P, Banda A, Bayliss J, Hawes D, Yang F, Lee HJ, Shan M, Cieslik M, Qin T, Werner CK, Wahl DR, Lyssiotis CA, Bian Z, Shotwell JB, Yadav VN, Koschmann C, Chinnaiyan AM, Blüml S, Judkins AR, Venneti S.

Cancer Cell. 2020 Sep 14;38(3):334-349.e9. doi: 10.1016/j.ccell.2020.07.008. Epub 2020 Aug 13.

H3K27M-mutant diffuse midline glioma with extensive intratumoral microthrombi in a young adult with COVID-19-associated coagulopathy.

Pun M, Haggerty-Skeans J, Pratt D, Fudym Y, Al-Holou WN, Camelo-Piragua S, Venneti S.

Acta Neuropathol. 2020 Aug;140(2):227-229. doi: 10.1007/s00401-020-02184-0. Epub 2020 Jun 29.

Diffuse intrinsic pontine glioma-like tumor with EZHIP expression and molecular features of PFA ependymoma.

Pratt D, Quezado M, Abdullaev Z, Hawes D, Yang F, Garton HJL, Judkins AR, Mody R, Chinnaiyan A, Aldape K, Koschmann C, Venneti S.

Acta Neuropathol Commun. 2020 Mar 20;8(1):37. doi: 10.1186/s40478-020-00905-w.

SWI/SNF complex heterogeneity is related to polyphenotypic differentiation, prognosis, and immune response in rhabdoid tumors.

Panwalkar P, Pratt D, Chung C, Dang D, Le P, Martinez D, Bayliss JM, Smith KS, Adam M, Potter S, Northcott PA, Mascarenhas L, Shows J, Pawel B, Margol A, Huang A, Judkins AR, Venneti S.

Neuro Oncol. 2020 Jun 9;22(6):785-796. doi: 10.1093/neuonc/noaa004.

2019

Glutamine Metabolism in Brain Tumors.

Natarajan SK, Venneti S.

Cancers (Basel). 2019 Oct 24;11(11):1628. doi: 10.3390/cancers11111628.

Integrating ependymoma molecular subgroups into clinical trials.

Venneti S.

Neuro Oncol. 2019 Oct 9;21(10):1219-1220. doi: 10.1093/neuonc/noz132.

Poly Combs the Immune System: PRC2 Loss in Malignant Peripheral Nerve Sheath Tumors Can Dampen Immune Responses.

Natarajan SK, Venneti S.

Cancer Res. 2019 Jul 1;79(13):3172-3173. doi: 10.1158/0008-5472.CAN-19-1186.

2018

BRAF activating mutations involving the β3-αC loop in V600E-negative anaplastic pleomorphic xanthoastrocytoma.

Pratt D, Camelo-Piragua S, McFadden K, Leung D, Mody R, Chinnaiyan A, Koschmann C, Venneti S.

Acta Neuropathol Commun. 2018 Mar 15;6(1):24. doi: 10.1186/s40478-018-0525-1.

Circumscribed/non-diffuse histology confers a better prognosis in H3K27M-mutant gliomas.

Pratt D, Natarajan SK, Banda A, Giannini C, Vats P, Koschmann C, Mody R, Chinnaiyan A, Venneti S.

Acta Neuropathol. 2018 Feb;135(2):299-301. doi: 10.1007/s00401-018-1805-3. Epub 2018 Jan 4.

2017

Glutaminolysis: A Hallmark of Cancer Metabolism.

Yang L, Venneti S, Nagrath D.

Annu Rev Biomed Eng. 2017 Jun 21;19:163-194. doi: 10.1146/annurev-bioeng-071516-044546. Epub 2017 Mar 8.

Immunohistochemical analysis of H3K27me3 demonstrates global reduction in group-A childhood posterior fossa ependymoma and is a powerful predictor of outcome.

Panwalkar P, Clark J, Ramaswamy V, Hawes D, Yang F, Dunham C, Yip S, Hukin J, Sun Y, Schipper MJ, Chavez L, Margol A, Pekmezci M, Chung C, Banda A, Bayliss JM, Curry SJ, Santi M, Rodriguez FJ, Snuderl M, Karajannis MA, Saratsis AM, Horbinski CM, Carret AS, Wilson B, Johnston D, Lafay-Cousin L, Zelcer S, Eisenstat D, Silva M, Scheinemann K, Jabado N, McNeely PD, Kool M, Pfister SM, Taylor MD, Hawkins C, Korshunov A, Judkins AR, Venneti S.

Acta Neuropathol. 2017 Nov;134(5):705-714. doi: 10.1007/s00401-017-1752-4. Epub 2017 Jul 21.

Metabolic Reprogramming in Brain Tumors.

Venneti S, Thompson CB.

Annu Rev Pathol. 2017 Jan 24;12:515-545. doi: 10.1146/annurev-pathol-012615-044329. Epub 2016 Dec 21.

2016

Lowered H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas.

Bayliss J, Mukherjee P, Lu C, Jain SU, Chung C, Martinez D, Sabari B, Margol AS, Panwalkar P, Parolia A, Pekmezci M, McEachin RC, Cieslik M, Tamrazi B, Garcia BA, La Rocca G, Santi M, Lewis PW, Hawkins C, Melnick A, David Allis C, Thompson CB, Chinnaiyan AM, Judkins AR, Venneti S.

Sci Transl Med. 2016 Nov 23;8(366):366ra161. doi: 10.1126/scitranslmed.aah6904.

Non-invasive metabolic imaging of brain tumours in the era of precision medicine.

Kim MM, Parolia A, Dunphy MP, Venneti S.

Nat Rev Clin Oncol. 2016 Dec;13(12):725-739. doi: 10.1038/nrclinonc.2016.108. Epub 2016 Jul 19.

2015
2-Hydoxyglutarate: D/Riving Pathology in gLiomaS.

Wahl DR, Venneti S.

Brain Pathol. 2015 Nov;25(6):760-8. doi: 10.1111/bpa.12309.

Metabolic Reprogramming in Brain Cancer: A Coordinated Effort.

Venneti S, Mischel PS.

Brain Pathol. 2015 Nov;25(6):753-4. doi: 10.1111/bpa.12308.

Detection of human brain tumor infiltration with quantitative stimulated Raman scattering microscopy.

Ji M, Lewis S, Camelo-Piragua S, Ramkissoon SH, Snuderl M, Venneti S, Fisher-Hubbard A, Garrard M, Fu D, Wang AC, Heth JA, Maher CO, Sanai N, Johnson TD, Freudiger CW, Sagher O, Xie XS, Orringer DA.

Sci Transl Med. 2015 Oct 14;7(309):309ra163. doi: 10.1126/scitranslmed.aab0195.

Hypoxia Induces Production of L-2-Hydroxyglutarate.

Intlekofer AM, Dematteo RG, Venneti S, Finley LW, Lu C, Judkins AR, Rustenburg AS, Grinaway PB, Chodera JD, Cross JR, Thompson CB.

Cell Metab. 2015 Aug 4;22(2):304-11. doi: 10.1016/j.cmet.2015.06.023. Epub 2015 Jul 23.

Feedback circuitry between miR-218 repression and RTK activation in glioblastoma.

Mathew LK, Huangyang P, Mucaj V, Lee SS, Skuli N, Eisinger-Mathason TS, Biju K, Li B, Venneti S, Lal P, Lathia JD, Rich JN, Keith B, Simon MC.

Sci Signal. 2015 May 5;8(375):ra42. doi: 10.1126/scisignal.2005978.

MicroRNA-124 expression counteracts pro-survival stress responses in glioblastoma.

Mucaj V, Lee SS, Skuli N, Giannoukos DN, Qiu B, Eisinger-Mathason TS, Nakazawa MS, Shay JE, Gopal PP, Venneti S, Lal P, Minn AJ, Simon MC, Mathew LK.Oncogene. 2015 Apr 23;34(17):2204-14. doi: 10.1038/onc.2014.168. Epub 2014 Jun 23.

The evolving molecular genetics of low-grade glioma.

Venneti S, Huse JT.

Adv Anat Pathol. 2015 Mar;22(2):94-101. doi: 10.1097/PAP.0000000000000049.

Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo.

Venneti S, Dunphy MP, Zhang H, Pitter KL, Zanzonico P, Campos C, Carlin SD, La Rocca G, Lyashchenko S, Ploessl K, Rohle D, Omuro AM, Cross JR, Brennan CW, Weber WA, Holland EC, Mellinghoff IK, Kung HF, Lewis JS, Thompson CB.

Sci Transl Med. 2015 Feb 11;7(274):274ra17. doi: 10.1126/scitranslmed.aaa1009.

2014

Serine catabolism regulates mitochondrial redox control during hypoxia.

Ye J, Fan J, Venneti S, Wan YW, Pawel BR, Zhang J, Finley LW, Lu C, Lindsten T, Cross JR, Qing G, Liu Z, Simon MC, Rabinowitz JD, Thompson CB.

Cancer Discov. 2014 Dec;4(12):1406-17. doi: 10.1158/2159-8290.CD-14-0250. Epub 2014 Sep 3.

A sensitive and specific histopathologic prognostic marker for H3F3A K27M mutant pediatric glioblastomas.

Venneti S, Santi M, Felicella MM, Yarilin D, Phillips JJ, Sullivan LM, Martinez D, Perry A, Lewis PW, Thompson CB, Judkins AR.

Acta Neuropathol. 2014 Nov;128(5):743-53. doi: 10.1007/s00401-014-1338-3. Epub 2014 Sep 9.

Asparagine plays a critical role in regulating cellular adaptation to glutamine depletion.

Zhang J, Fan J, Venneti S, Cross JR, Takagi T, Bhinder B, Djaballah H, Kanai M, Cheng EH, Judkins AR, Pawel B, Baggs J, Cherry S, Rabinowitz JD, Thompson CB.

Mol Cell. 2014 Oct 23;56(2):205-218. doi: 10.1016/j.molcel.2014.08.018. Epub 2014 Sep 18.

Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation.

Lee JV, Carrer A, Shah S, Snyder NW, Wei S, Venneti S, Worth AJ, Yuan ZF, Lim HW, Liu S, Jackson E, Aiello NM, Haas NB, Rebbeck TR, Judkins A, Won KJ, Chodosh LA, Garcia BA, Stanger BZ, Feldman MD, Blair IA, Wellen KE.

Cell Metab. 2014 Aug 5;20(2):306-319. doi: 10.1016/j.cmet.2014.06.004. Epub 2014 Jul 3.

miR-218 opposes a critical RTK-HIF pathway in mesenchymal glioblastoma.

Mathew LK, Skuli N, Mucaj V, Lee SS, Zinn PO, Sathyan P, Imtiyaz HZ, Zhang Z, Davuluri RV, Rao S, Venneti S, Lal P, Lathia JD, Rich JN, Keith B, Minn AJ, Simon MC.

Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):291-6. doi: 10.1073/pnas.1314341111. Epub 2013 Dec 24.

2013

Induction of sarcomas by mutant IDH2.

Lu C, Venneti S, Akalin A, Fang F, Ward PS, Dematteo RG, Intlekofer AM, Chen C, Ye J, Hameed M, Nafa K, Agaram NP, Cross JR, Khanin R, Mason CE, Healey JH, Lowe SW, Schwartz GK, Melnick A, Thompson CB.

Genes Dev. 2013 Sep 15;27(18):1986-98. doi: 10.1101/gad.226753.113.

PDGFRA amplification is common in pediatric and adult high-grade astrocytomas and identifies a poor prognostic group in IDH1 mutant glioblastoma.

Phillips JJ, Aranda D, Ellison DW, Judkins AR, Croul SE, Brat DJ, Ligon KL, Horbinski C, Venneti S, Zadeh G, Santi M, Zhou S, Appin CL, Sioletic S, Sullivan LM, Martinez-Lage M, Robinson AE, Yong WH, Cloughesy T, Lai A, Phillips HS, Marshall R, Mueller S, Haas-Kogan DA, Molinaro AM, Perry A.

Brain Pathol. 2013 Sep;23(5):565-73. doi: 10.1111/bpa.12043. Epub 2013 Mar 18.

Evaluation of histone 3 lysine 27 trimethylation (H3K27me3) and enhancer of Zest 2 (EZH2) in pediatric glial and glioneuronal tumors shows decreased H3K27me3 in H3F3A K27M mutant glioblastomas.

Venneti S, Garimella MT, Sullivan LM, Martinez D, Huse JT, Heguy A, Santi M, Thompson CB, Judkins AR.

Brain Pathol. 2013 Sep;23(5):558-64. doi: 10.1111/bpa.12042. Epub 2013 Mar 6.

Immunohistochemical expression of glypican-3 in pediatric tumors: an analysis of 414 cases.

Chan ES, Pawel BR, Corao DA, Venneti S, Russo P, Santi M, Sullivan LM.

Pediatr Dev Pathol. 2013 Jul-Aug;16(4):272-7. doi: 10.2350/12-06-1216-OA.1. Epub 2013 Mar 26.

Histone 3 lysine 9 trimethylation is differentially associated with isocitrate dehydrogenase mutations in oligodendrogliomas and high-grade astrocytomas.

Venneti S, Felicella MM, Coyne T, Phillips JJ, Gorovets D, Huse JT, Kofler J, Lu C, Tihan T, Sullivan LM, Santi M, Judkins AR, Perry A, Thompson CB.

J Neuropathol Exp Neurol. 2013 Apr;72(4):298-306. doi: 10.1097/NEN.0b013e3182898113.

Metabolic modulation of epigenetics in gliomas.

Venneti S, Thompson CB.

Brain Pathol. 2013 Mar;23(2):217-21. doi: 10.1111/bpa.12022.

Endoscopic endonasal resection of anterior skull base meningiomas and mucosa: implications for resection, reconstruction, and recurrence.

Lee JY, Barroeta JE, Newman JG, Chiu AG, Venneti S, Grady MS.

J Neurol Surg A Cent Eur Neurosurg. 2013 Jan;74(1):12-7. doi: 10.1055/s-0032-1322594. Epub 2012 Oct 26.

Molecular imaging of microglia/macrophages in the brain.

Venneti S, Lopresti BJ, Wiley CA.

Glia. 2013 Jan;61(1):10-23. doi: 10.1002/glia.22357. Epub 2012 May 21

2012

Optic nerve biopsy in the management of progressive optic neuropathy.

Levin MH, Ney JJ, Venneti S, Moster ML, Balcer LJ, Volpe NJ, Gausas RE, Liu GT, Vagefi MR, Galetta SL.

J Neuroophthalmol. 2012 Dec;32(4):313-20. doi: 10.1097/WNO.0b013e31825be81e.

MiRNA-9 and MiRNA-200a distinguish hemangioblastomas from metastatic clear cell renal cell carcinomas in the CNS.

Venneti S, Boateng LA, Friedman JR, Baldwin DA, Tobias JW, Judkins AR, Mourelatos Z, Lal P.

Brain Pathol. 2012 Jul;22(4):522-9. doi: 10.1111/j.1750-3639.2011.00551.x. Epub 2011 Dec 9.

2011

Simulated brain biopsy for diagnosing neurodegeneration using autopsy-confirmed cases.

Venneti S, Robinson JL, Roy S, White MT, Baccon J, Xie SX, Trojanowski JQ.

Acta Neuropathol. 2011 Dec;122(6):737-45. doi: 10.1007/s00401-011-0880-5. Epub 2011 Sep 30.

Malignant rhabdoid tumors express stem cell factors, which relate to the expression of EZH2 and Id proteins.

Venneti S, Le P, Martinez D, Xie SX, Sullivan LM, Rorke-Adams LB, Pawel B, Judkins AR.

Am J Surg Pathol. 2011 Oct;35(10):1463-72. doi: 10.1097/PAS.0b013e318224d2cd.

Ganglioglioma arising from dysplastic cortex.

Ortiz-González XR, Venneti S, Biegel JA, Rorke-Adams LB, Porter BE.

Epilepsia. 2011 Sep;52(9):e106-8. doi: 10.1111/j.1528-1167.2011.03124.x. Epub 2011 Jun 10.

Isocitrate dehydrogenase 1 analysis differentiates gangliogliomas from infiltrative gliomas.

Horbinski C, Kofler J, Yeaney G, Camelo-Piragua S, Venneti S, Louis DN, Perry A, Murdoch G, Nikiforova M.

Brain Pathol. 2011 Sep;21(5):564-74. doi: 10.1111/j.1750-3639.2011.00480.x. Epub 2011 Mar 14.

p16INK4A and p14ARF tumor suppressor pathways are deregulated in malignant rhabdoid tumors.

Venneti S, Le P, Martinez D, Eaton KW, Shyam N, Jordan-Sciutto KL, Pawel B, Biegel JA, Judkins AR.

J Neuropathol Exp Neurol. 2011 Jul;70(7):596-609. doi: 10.1097/NEN.0b013e31822146ca.

Asymmetric bilateral demyelinating optic neuropathy from tacrolimus toxicity.

Venneti S, Moss HE, Levin MH, Vagefi MR, Brozena SC, Pruitt AA, Mourelatos Z, Trojanowski JQ, Galetta SL, Balcer LJ.

J Neurol Sci. 2011 Feb 15;301(1-2):112-5. doi: 10.1016/j.jns.2010.10.014. Epub 2010 Nov 26.

2000-2010

Prion diseases.

Venneti S.

Clin Lab Med. 2010 Mar;30(1):293-309. doi: 10.1016/j.cll.2009.11.002.

PK11195 labels activated microglia in Alzheimer's disease and in vivo in a mouse model using PET.

Venneti S, Lopresti BJ, Wang G, Hamilton RL, Mathis CA, Klunk WE, Apte UM, Wiley CA.

Neurobiol Aging. 2009 Aug;30(8):1217-26. doi: 10.1016/j.neurobiolaging.2007.11.005. Epub 2008 Feb 21.

Imaging microglial activation during neuroinflammation and Alzheimer's disease.

Venneti S, Wiley CA, Kofler J.

J Neuroimmune Pharmacol. 2009 Jun;4(2):227-43. doi: 10.1007/s11481-008-9142-2. Epub 2008 Dec 4.

Carbon 11-labeled Pittsburgh Compound B and carbon 11-labeled (R)-PK11195 positron emission tomographic imaging in Alzheimer disease.

Wiley CA, Lopresti BJ, Venneti S, Price J, Klunk WE, DeKosky ST, Mathis CA.

Arch Neurol. 2009 Jan;66(1):60-7. doi: 10.1001/archneurol.2008.511.

The positron emission tomography ligand DAA1106 binds with high affinity to activated microglia in human neurological disorders.

Venneti S, Wang G, Nguyen J, Wiley CA.

J Neuropathol Exp Neurol. 2008 Oct;67(10):1001-10. doi: 10.1097/NEN.0b013e318188b204.

Longitudinal in vivo positron emission tomography imaging of infected and activated brain macrophages in a macaque model of human immunodeficiency virus encephalitis correlates with central and peripheral markers of encephalitis and areas of synaptic degeneration.

Venneti S, Bonneh-Barkay D, Lopresti BJ, Bissel SJ, Wang G, Mathis CA, Piatak M Jr, Lifson JD, Nyaundi JO, Murphey-Corb M, Wiley CA.

Am J Pathol. 2008 Jun;172(6):1603-16. doi: 10.2353/ajpath.2008.070967. Epub 2008 May 8.

The high affinity peripheral benzodiazepine receptor ligand DAA1106 binds to activated and infected brain macrophages in areas of synaptic degeneration: implications for PET imaging of neuroinflammation in lentiviral encephalitis.

Venneti S, Wang G, Wiley CA.

Neurobiol Dis. 2008 Feb;29(2):232-41. doi: 10.1016/j.nbd.2007.08.016. Epub 2007 Sep 7.

Activated macrophages in HIV encephalitis and a macaque model show increased [3H](R)-PK11195 binding in a PI3-kinase-dependent manner.

Venneti S, Wang G, Wiley CA.

Neurosci Lett. 2007 Oct 16;426(2):117-22. doi: 10.1016/j.neulet.2007.08.053. Epub 2007 Aug 31.

The high affinity peripheral benzodiazepine receptor ligand DAA1106 binds specifically to microglia in a rat model of traumatic brain injury: implications for PET imaging.

Venneti S, Wagner AK, Wang G, Slagel SL, Chen X, Lopresti BJ, Mathis CA, Wiley CA.

Exp Neurol. 2007 Sep;207(1):118-27. doi: 10.1016/j.expneurol.2007.06.003. Epub 2007 Jun 19.

A comparison of the high-affinity peripheral benzodiazepine receptor ligands DAA1106 and (R)-PK11195 in rat models of neuroinflammation: implications for PET imaging of microglial activation.

Venneti S, Lopresti BJ, Wang G, Slagel SL, Mason NS, Mathis CA, Fischer ML, Larsen NJ, Mortimer AD, Hastings TG, Smith AD, Zigmond MJ, Suhara T, Higuchi M, Wiley CA.

J Neurochem. 2007 Sep;102(6):2118-2131. doi: 10.1111/j.1471-4159.2007.04690.x. Epub 2007 Jun 7.

The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: from pathology to imaging.

Venneti S, Lopresti BJ, Wiley CA.

Prog Neurobiol. 2006 Dec;80(6):308-22. doi: 10.1016/j.pneurobio.2006.10.002. Epub 2006 Dec 6.

PET imaging of brain macrophages using the peripheral benzodiazepine receptor in a macaque model of neuroAIDS.

Venneti S, Lopresti BJ, Wang G, Bissel SJ, Mathis CA, Meltzer CC, Boada F, Capuano S 3rd, Kress GJ, Davis DK, Ruszkiewicz J, Reynolds IJ, Murphey-Corb M, Trichel AM, Wisniewski SR, Wiley CA.

J Clin Invest. 2004 Apr;113(7):981-9. doi: 10.1172/JCI20227.

NMDA and glutamate evoke excitotoxicity at distinct cellular locations in rat cortical neurons in vitro.

Sinor JD, Du S, Venneti S, Blitzblau RC, Leszkiewicz DN, Rosenberg PA, Aizenman E.

J Neurosci. 2000 Dec 1;20(23):8831-7. doi: 10.1523/JNEUROSCI.20-23-08831.2000.